FLOWX | FSDPX | FLOWX / FSDPX | |
Total Expense Ratio | 0.93 | 0.70 | 133% |
Annual Report Gross Expense Ratio | 0.93 | 0.70 | 133% |
Fund Existence | 5 years | 39 years | - |
Gain YTD | 6.357 | 1.273 | 499% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 109M | 705M | 15% |
Annual Yield % from dividends | 0.71 | 0.97 | 73% |
Returns for 1 year | 2.61 | -15.42 | -17% |
Returns for 3 years | 37.05 | -14.55 | -255% |
Returns for 5 years | 80.56 | 50.51 | 159% |
Returns for 10 years | N/A | 10.56 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PBE | 60.33 | 0.44 | +0.73% |
Invesco Biotechnology & Genome ETF | |||
ILTB | 48.53 | 0.18 | +0.37% |
iShares Core 10+ Year USD Bond ETF | |||
GVI | 105.88 | 0.02 | +0.02% |
iShares Intermediate Govt/Crdt Bd ETF | |||
EQRR | 56.32 | -0.05 | -0.09% |
ProShares Equities for Rising Rates ETF | |||
GLDI | 163.00 | -0.50 | -0.31% |
UBS ETRACS Gold Shares Covered Call ETN |